Chandan Healthcare Limited

LISTED 🏛️ NSE SME

NSE SME IPO · IPO Guide

📄 View RHP

Issue Price

₹151 – ₹159

Listed On

17 Feb 2025

Listing Price

₹265.10 (+66.73%)

Current Price

₹265.10 (+66.73%)

🧮

Lot Size Calculator (Rs 159/share)

🎁 1 Special Quota Available

🎁 Special Quotas:

👔 Employee Quota: 2,45,600 shares

Application	Lots	Shares	Amount
🏷️ Retail (Min)	1	800	₹1,27,200
🏷️ Retail (Max)	2	1,600	₹2,54,400
👔 Employee Quota (Min)	1	800	₹1,27,200
💼 S-HNI (Min)	3	2,400	₹3,81,600
💼 S-HNI (Max)	7	5,600	₹8,90,400
💼 B-HNI (Min)	8	6,400	₹10,17,600

As per financials, Chandan Healthcare Limited has shown good growth, RoNW is 39.54% and P/E is respectively 108.41, 23.77 and 16.74 as per FY23, FY24 and annualized FY25 earnings. So, issue looks fully priced, but sudden rise in net-profit just before IPO raises doubts. Company is a diagnostic company with network in North India providing pathology and radiology testing services, which is highly competitive business segment. So, we give NEUTRAL rating for this IPO. Readers must consult a qualified financial advisor prior to making any actual investment decisions.

As on Date	QIB	NII	RII	Employee	Total
Shares Offered / Reserved	12,33,600	9,25,600	21,59,200	2,45,600	45,64,000
Day 1 10-02-25	0 (0)	1,88,800 (0.2)	6,35,200 (0.29)	9,600 (0.04)	8,33,600 (0.18)
Day 2 11-02-25	0 (0)	7,01,600 (0.76)	17,03,200 (0.79)	15,200 (0.06)	24,20,000 (0.53)
Day 3 12-02-25	93,56,800 (7.58)	1,77,91,200 (19.22)	52,72,800 (2.44)	51,200 (0.21)	3,24,72,000 (7.11)

Open Date	Feb 10, 2025
Close Date	Feb 12, 2025
Allotment Date	Feb 14, 2025
Listing Date	Feb 17, 2025
Listing Platform	NSE SME
Face Value	₹ 10 Per Equity Share
Issue Price	₹ 151 to ₹ 159 Per Equity Share
Issue Size	Total Issue of up to 67,52,000 Equity Shares aggregating up to ₹107.36 Cr Fresh Issue of up to 44,52,064 Equity Shares aggregating up to ₹70.79 Cr Offer for Sale of up to 22,99,936 Equity Shares aggregating up to ₹36.57 Cr
Retail Min Lot	1 Lot (800 Shares - ₹ 1,27,200)
Lead Manager	Unistone Capital Private Limited

Offer for Sale

1
Offer for Sale(a) Sell upto 22,99,936 equity shares (Rs 36.57/- Cr) of the selling shareholders of the company.Fresh Issue(a) Setting up of a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh. ( Rs 32.82/- Cr )(b) Setting up of a new Central Reference laboratory at Ayodhya, Uttar Pradesh. ( Rs 7.10/- Cr )(c) Setting up of a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh. ( Rs 7.10/- Cr )(d) General corporate purposes.(e) To meet out the Offer Expenses.
2
Offer for Sale(a) Sell upto 22,99,936 equity shares (Rs 36.57/- Cr) of the selling shareholders of the company.

Fresh Issue

1
Fresh Issue(a) Setting up of a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh. ( Rs 32.82/- Cr )(b) Setting up of a new Central Reference laboratory at Ayodhya, Uttar Pradesh. ( Rs 7.10/- Cr )(c) Setting up of a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh. ( Rs 7.10/- Cr )(d) General corporate purposes.(e) To meet out the Offer Expenses.
2
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decision
3
Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this applicatio
4
With entry barriers, SEBI wants only well informed investors to participate is such SME offer
5
With crazy recent listings, SME IPOs have started drawing attention of investors across the boar
6
However, as SME issues have entry barriers and continued low preference from broking community, any reader taking decisions based on any information published here does so entirely at own ris
7
Above information is based on information available as on date coupled with market perception

✅ Check Your SME IPO Allotment Result

Direct link to registrar — query by PAN / Application No. / DP Client ID.

⚠️

Disclaimer

No financial information whatsoever published herein, should be construed as an offer to buy or sell securities, or as information to make investment decisions, or as an official confirmation of any transaction. All matter published herein is purely for educational and informational purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor prior to making any actual investment decisions.

Period	Total Income	Total Expenses	Profit After Tax (PAT)
31.12.24 FY25	167.99	144.58	17.42
FY24	177.96	156.50	16.36
FY23	137.03	132.02	3.59
FY22	119.92	120.98	(1.09)

Company	P/B Ratio	P/E Ratio	RoNW	Total Revenue (Cr)
Chandan Healthcare Limited Current	5.86	23.8	39.5%	178
Vijaya Diagnostic Centre Limited	16.4	88.8	17.8%	627
Dr Lal Pathlabs Limited	11.7	56.1	20.4%	2,404
Metropolis Healthcare Limited	7.94	61.2	12.2%	1,317

Chandan Healthcare Limited

Lot Size Calculator (Rs 159/share)

SME IPO Review

SME IPO Timeline

IPO Subscription

Valuations (Post Issue FY24)

Company Financials

SME IPO At a Glance

Peers Comparison (As per FY26 / TTM)

About Company

Issue Objectives

Company Promoters

✅ Check Your SME IPO Allotment Result

Disclaimer

💬 Community Discussion

✍️ Post a Comment

🔍 Check IPO Allotment Status